Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 18, 2021, Phebe N. Novakovic informed the Board of Directors of her
decision not to stand for re-election at the end of her current term expiring at
the 2021 annual shareholders meeting in April.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
On February 19, 2021, Abbott's Board of Directors amended the first sentence of
Article III, Section 2 of Abbott's by-laws to provide that Abbott's Board of
Directors shall consist of thirteen persons, effective April 23, 2021. Abbott's
by-laws currently provide that the Board of Directors consists of fourteen
Item 9.01 Financial Statements and Exhibits
Exhibit No. Exhibit
3.1 By-Laws of Abbott Laboratories, as amended and restated, effective
April 23, 2021.
104 Cover Page Interactive Data File (the cover page XBRL tags are
embedded in the Inline XBRL document).
© Edgar Online, source Glimpses